Results 111 to 120 of about 683 (135)
Some of the next articles are maybe not open access.

Azilsartan medoxomil (Edarbi) the eighth ARB.

The Medical letter on drugs and therapeutics, 2011
The angiotensin receptor blocker (ARB) azilsartan medoxomil (Edarbi-Takeda) was recently approved by the FDA for oral treatment of hypertension, either alone or combined with other drugs. It is the eighth ARB approved for this indication.
openaire   +1 more source

Formulation and evaluation of solid self-microemulsifying drug delivery system for azilsartan medoxomil

International Journal of Polymeric Materials and Polymeric Biomaterials, 2021
Jyotsana Madan, , Kamal Dua
exaly  

DRUG UTILIZATION STUDY FOR AZILSARTAN MEDOXOMIL IN GERMANY

Journal of Hypertension, 2018
B. Ehlken   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy